Tag Archives: says

Xanax recalled over ‘foreign substance’ concerns, FDA says

At least one lot of a popular anti-anxiety drug is facing a nationwide recall over concerns there is a “potential presence of [a] foreign substance,” in the product, the Food and Drug Administration (FDA) announced late last week. Mylan Pharmaceuticals is voluntarily recalling one lot of its Alprazolam Tablets, a prescription drug typically sold under… Read More »

AWS says Amazon Textract is now HIPAA-eligible

In another big move aimed at its healthcare clients, Amazon Web Services revealed this week that its Textract machine learning technology – which can help healthcare organizations more easily extract data from scanned documents – is now HIPAA eligible, joining a half-dozen other cloud-based AI tools. WHY IT MATTERSIt’s important to note that HIPAA-eligible is… Read More »